ethylmaleimide has been researched along with Primary Myelofibrosis in 1 studies
Ethylmaleimide: A sulfhydryl reagent that is widely used in experimental biochemical studies.
Primary Myelofibrosis: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KIMBER, RJ | 1 |
| LANDER, H | 1 |
| ROBSON, HN | 1 |
1 other study available for ethylmaleimide and Primary Myelofibrosis
| Article | Year |
|---|---|
THE SEQUESTRATION OF NEM-TREATED RED CELLS IN NORMAL AND ABNORMAL SUBJECTS: A TEST OF SPLENIC UPTAKE FUNCTION.
Topics: Anemia; Anemia, Hemolytic; Erythrocytes; Ethylmaleimide; Hodgkin Disease; Humans; Liver; Liver Cirrh | 1965 |